Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection

被引:1
作者
Martinot, Amanda J. [1 ,2 ]
Cox, Freek [3 ]
Abbink, Peter [1 ]
Hecht, Jonathan L. [4 ]
Bronson, Roderick [5 ]
Borducchi, Erica N. [1 ]
Rinaldi, William J. [6 ]
Ferguson, Melissa J. [6 ]
de la Barrera, Rafael A. [7 ]
Zahn, Roland [3 ]
Van der Fits, Leslie [3 ]
Barouch, Dan H. [1 ,8 ]
机构
[1] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[2] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth & Comparat Pathobiol, North Grafton, MA 01536 USA
[3] Janssen Vaccines & Prevent, Leiden, Netherlands
[4] Beth Israel Deaconess Med Ctr, Div Anat Pathol, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Alphagenesis, Yemassee, SC USA
[7] Walter Reed Army Inst Res, Silver Spring, MD USA
[8] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA
关键词
DOUBLE-BLIND; IMMUNOGENICITY; SAFETY; PREVENTION; EFFICACY; GUIDANCE; PHASE-1; REGIMEN;
D O I
10.1038/s41541-024-00927-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At the start of the Zika virus (ZIKV) epidemic in 2015, ZIKV spread across South and Central America, and reached parts of the southern United States placing pregnant women at risk for fetal microcephaly, fetal loss, and other adverse pregnancy outcomes associated with congenital ZIKA syndrome (CZS). For this reason, testing of a safe and efficacious ZIKV vaccine remains a global health priority. Here we report that a single immunization with Ad26.M.Env ZIKV vaccine, when administered prior to conception, fully protects pregnant rhesus macaques from ZIKV viral RNA in blood and tissues with no adverse effects in dams and fetuses. Furthermore, vaccination prevents ZIKV distribution to fetal tissues including the brain. ZIKV associated neuropathology was absent in offspring of Ad26.M.Env vaccinated dams, although pathology was limited in fetuses from non-immunized, challenged dams. Vaccine efficacy is associated with induction of ZIKV neutralizing antibodies in pregnant rhesus macaques. These data suggest the feasibility of vaccine prevention of CZS in humans.
引用
收藏
页数:12
相关论文
共 58 条
  • [1] Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
    Abbink, Peter
    Lemckert, Angelique A. C.
    Ewald, Bonnie A.
    Lynch, Diana M.
    Denholtz, Matthew
    Smits, Shirley
    Holterman, Lennart
    Damen, Irma
    Vogels, Ronald
    Thorner, Anna R.
    O'Brien, Kara L.
    Carville, Angela
    Mansfield, Keith G.
    Goudsmit, Jaap
    Havenga, Menzo J. E.
    Barouch, Dan H.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (09) : 4654 - 4663
  • [2] Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
    Abbink, Peter
    Larocca, Rafael A.
    De La Barrera, Rafael A.
    Bricault, Christine A.
    Moseley, Edward T.
    Boyd, Michael
    Kirilova, Marinela
    Li, Zhenfeng
    Ng'ang'a, David
    Nanayakkara, Ovini
    Nityanandam, Ramya
    Mercado, Noe B.
    Borducchi, Erica N.
    Agarwal, Arshi
    Brinkman, Amanda L.
    Cabral, Crystal
    Chandrashekar, Abishek
    Giglio, Patricia B.
    Jetton, David
    Jimenez, Jessica
    Lee, Benjamin C.
    Mojta, Shanell
    Molloy, Katherine
    Shetty, Mayuri
    Neubauer, George H.
    Stephenson, Kathryn E.
    Peron, Jean Pierre S.
    Zanotto, Paolo M. de A.
    Misamore, Johnathan
    Finneyfrock, Brad
    Lewis, Mark G.
    Alter, Galit
    Modjarrad, Kayvon
    Jarman, Richard G.
    Eckels, Kenneth H.
    Michael, Nelson L.
    Thomas, Stephen J.
    Barouch, Dan H.
    [J]. SCIENCE, 2016, 353 (6304) : 1129 - 1132
  • [3] Teratogenic effects of the Zika virus and the role of the placenta
    Adibi, Jennifer J.
    Marques, Ernesto T. A., Jr.
    Cartus, Abigail
    Beigi, Richard H.
    [J]. LANCET, 2016, 387 (10027) : 1587 - 1590
  • [4] Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys
    Aid, Malika
    Abbink, Peter
    Larocca, Rafael A.
    Boyd, Michael
    Nityanandam, Ramya
    Nanayakkara, Ovini
    Martinot, Amanda J.
    Moseley, Edward T.
    Blass, Eryn
    Borducchi, Erica N.
    Chandrashekar, Abishek
    Brinkman, Amanda L.
    Molloy, Katherine
    Jetton, David
    Tartaglia, Lawrence J.
    Liu, Jinyan
    Best, Katharine
    Perelson, Alan S.
    De la Barrera, Rafael A.
    Lewis, Mark G.
    Barouch, Dan H.
    [J]. CELL, 2017, 169 (04) : 610 - 620
  • [5] [Anonymous], 2016, Situation Report Zika Virus Disease
  • [6] Neonatal Development in Prenatally Zika Virus-Exposed Infant Macaques with Dengue Immunity
    Ausderau, Karla
    Kabakov, Sabrina
    Razo, Elaina
    Mitzey, Ann M.
    Bach, Kathryn M.
    Crooks, Chelsea M.
    Dulaney, Natalie
    Keding, Logan
    Salas-Quinchucua, Cristhian
    Medina-Magues, Lex G.
    Weiler, Andrea M.
    Bliss, Mason
    Eickhoff, Jens
    Simmons, Heather A.
    Mejia, Andres
    Antony, Kathleen M.
    Morgan, Terry
    Capuano, Saverio
    Schneider, Mary L.
    Aliota, Matthew T.
    Friedrich, Thomas C.
    O'Connor, David H.
    Golos, Thaddeus G.
    Mohr, Emma L.
    [J]. VIRUSES-BASEL, 2021, 13 (09):
  • [7] Prospects for a Zika Virus Vaccine
    Barouch, Dan H.
    Thomas, Stephen J.
    Michael, Nelson L.
    [J]. IMMUNITY, 2017, 46 (02) : 176 - 182
  • [8] International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
    Barouch, Dan H.
    Kik, Sandra V.
    Weverling, Gerrit J.
    Dilan, Rebecca
    King, Sharon L.
    Maxfield, Lori F.
    Clark, Sarah
    Ng'ang'a, David
    Brandariz, Kara L.
    Abbink, Peter
    Sinangil, Faruk
    de Bruyn, Guy
    Gray, Glenda E.
    Roux, Surita
    Bekker, Linda-Gail
    Dilraj, Athmanundh
    Kibuuka, Hannah
    Robb, Merlin L.
    Michael, Nelson L.
    Anzala, Omu
    Amornkul, Pauli N.
    Gilmour, Jill
    Hural, John
    Buchbinder, Susan P.
    Seaman, Michael S.
    Dolin, Raphael
    Baden, Lindsey R.
    Carville, Angela
    Mansfield, Keith G.
    Pau, Maria G.
    Goudsmit, Jaap
    [J]. VACCINE, 2011, 29 (32) : 5203 - 5209
  • [9] Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
    Bockstal, Viki
    Leyssen, Maarten
    Heerwegh, Dirk
    Spiessens, Bart
    Robinson, Cynthia
    Stoop, Jeroen N.
    Roozendaal, Ramon
    Van Effelterre, Thierry
    Gaddah, Auguste
    Van Roey, Griet A.
    Solforosi, Laura
    Zahn, Roland
    Callendret, Benoit
    Hendriks, Jenny
    Luhn, Kerstin
    Douoguih, Macaya
    Schuitemaker, Hanneke
    Van Hoof, Johan
    [J]. NPJ VACCINES, 2022, 7 (01)
  • [10] An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
    Bollman, Brooke
    Nunna, Naveen
    Bahl, Kapil
    Hsiao, Chiaowen Joyce
    Bennett, Hamilton
    Butler, Scott
    Foreman, Bryant
    Burgomaster, Katherine E.
    Aleshnick, Maya
    Kong, Wing-Pui
    Fisher, Brian E.
    Ruckwardt, Tracy J.
    Morabito, Kaitlyn M.
    Graham, Barney S.
    Dowd, Kimberly A.
    Pierson, Theodore C.
    Carfi, Andrea
    [J]. NPJ VACCINES, 2023, 8 (01)